nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—CYP1A2—Dacarbazine—muscle cancer	0.229	0.455	CbGbCtD
Imiquimod—CYP1A2—Etoposide—muscle cancer	0.112	0.222	CbGbCtD
Imiquimod—CYP3A4—Vincristine—muscle cancer	0.0641	0.127	CbGbCtD
Imiquimod—CYP3A4—Etoposide—muscle cancer	0.0588	0.117	CbGbCtD
Imiquimod—CYP3A4—Doxorubicin—muscle cancer	0.0401	0.0795	CbGbCtD
Imiquimod—Myalgia—Vincristine—muscle cancer	0.00126	0.00254	CcSEcCtD
Imiquimod—Angiopathy—Etoposide—muscle cancer	0.00125	0.00251	CcSEcCtD
Imiquimod—Immune system disorder—Etoposide—muscle cancer	0.00124	0.0025	CcSEcCtD
Imiquimod—Mediastinal disorder—Etoposide—muscle cancer	0.00124	0.0025	CcSEcCtD
Imiquimod—Chills—Etoposide—muscle cancer	0.00123	0.00249	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00123	0.00248	CcSEcCtD
Imiquimod—Alopecia—Etoposide—muscle cancer	0.00121	0.00245	CcSEcCtD
Imiquimod—Cerebrovascular accident—Methotrexate—muscle cancer	0.00121	0.00245	CcSEcCtD
Imiquimod—Lethargy—Methotrexate—muscle cancer	0.00121	0.00245	CcSEcCtD
Imiquimod—Lymphadenopathy—Doxorubicin—muscle cancer	0.00121	0.00243	CcSEcCtD
Imiquimod—Oedema—Vincristine—muscle cancer	0.0012	0.00243	CcSEcCtD
Imiquimod—Infection—Vincristine—muscle cancer	0.0012	0.00241	CcSEcCtD
Imiquimod—Nervous system disorder—Vincristine—muscle cancer	0.00118	0.00238	CcSEcCtD
Imiquimod—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00118	0.00238	CcSEcCtD
Imiquimod—Decreased appetite—Dactinomycin—muscle cancer	0.00117	0.00236	CcSEcCtD
Imiquimod—Hyperhidrosis—Vincristine—muscle cancer	0.00116	0.00235	CcSEcCtD
Imiquimod—Fatigue—Dactinomycin—muscle cancer	0.00116	0.00235	CcSEcCtD
Imiquimod—Back pain—Etoposide—muscle cancer	0.00116	0.00233	CcSEcCtD
Imiquimod—Pain—Dactinomycin—muscle cancer	0.00115	0.00233	CcSEcCtD
Imiquimod—Anorexia—Vincristine—muscle cancer	0.00115	0.00232	CcSEcCtD
Imiquimod—Eczema—Doxorubicin—muscle cancer	0.00115	0.00231	CcSEcCtD
Imiquimod—Irritability—Methotrexate—muscle cancer	0.00114	0.00229	CcSEcCtD
Imiquimod—Feeling abnormal—Dactinomycin—muscle cancer	0.00111	0.00224	CcSEcCtD
Imiquimod—Ill-defined disorder—Etoposide—muscle cancer	0.00111	0.00224	CcSEcCtD
Imiquimod—Gastrointestinal pain—Dactinomycin—muscle cancer	0.0011	0.00222	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Vincristine—muscle cancer	0.0011	0.00221	CcSEcCtD
Imiquimod—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.00109	0.0022	CcSEcCtD
Imiquimod—Insomnia—Vincristine—muscle cancer	0.00109	0.0022	CcSEcCtD
Imiquimod—Paraesthesia—Vincristine—muscle cancer	0.00108	0.00218	CcSEcCtD
Imiquimod—Malaise—Etoposide—muscle cancer	0.00108	0.00218	CcSEcCtD
Imiquimod—Breast disorder—Methotrexate—muscle cancer	0.00107	0.00217	CcSEcCtD
Imiquimod—Purpura—Doxorubicin—muscle cancer	0.00107	0.00216	CcSEcCtD
Imiquimod—Abdominal pain—Dactinomycin—muscle cancer	0.00107	0.00215	CcSEcCtD
Imiquimod—Body temperature increased—Dactinomycin—muscle cancer	0.00107	0.00215	CcSEcCtD
Imiquimod—Cardiac failure—Doxorubicin—muscle cancer	0.00106	0.00213	CcSEcCtD
Imiquimod—Loss of consciousness—Etoposide—muscle cancer	0.00105	0.00212	CcSEcCtD
Imiquimod—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00105	0.00212	CcSEcCtD
Imiquimod—Lethargy—Doxorubicin—muscle cancer	0.00105	0.00212	CcSEcCtD
Imiquimod—Decreased appetite—Vincristine—muscle cancer	0.00105	0.00211	CcSEcCtD
Imiquimod—Cough—Etoposide—muscle cancer	0.00104	0.0021	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Vincristine—muscle cancer	0.00104	0.0021	CcSEcCtD
Imiquimod—Fatigue—Vincristine—muscle cancer	0.00104	0.0021	CcSEcCtD
Imiquimod—Convulsion—Etoposide—muscle cancer	0.00104	0.00209	CcSEcCtD
Imiquimod—Hypertension—Etoposide—muscle cancer	0.00103	0.00208	CcSEcCtD
Imiquimod—Pain—Vincristine—muscle cancer	0.00103	0.00208	CcSEcCtD
Imiquimod—Pain in extremity—Doxorubicin—muscle cancer	0.00103	0.00208	CcSEcCtD
Imiquimod—Chest pain—Etoposide—muscle cancer	0.00102	0.00205	CcSEcCtD
Imiquimod—Migraine—Doxorubicin—muscle cancer	0.00101	0.00204	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00101	0.00204	CcSEcCtD
Imiquimod—Discomfort—Etoposide—muscle cancer	0.00101	0.00203	CcSEcCtD
Imiquimod—Face oedema—Doxorubicin—muscle cancer	0.000994	0.00201	CcSEcCtD
Imiquimod—Hypersensitivity—Dactinomycin—muscle cancer	0.000993	0.002	CcSEcCtD
Imiquimod—Gastrointestinal pain—Vincristine—muscle cancer	0.000985	0.00199	CcSEcCtD
Imiquimod—Pancytopenia—Methotrexate—muscle cancer	0.000976	0.00197	CcSEcCtD
Imiquimod—Infection—Etoposide—muscle cancer	0.000969	0.00196	CcSEcCtD
Imiquimod—Asthenia—Dactinomycin—muscle cancer	0.000967	0.00195	CcSEcCtD
Imiquimod—Dysuria—Methotrexate—muscle cancer	0.000961	0.00194	CcSEcCtD
Imiquimod—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000955	0.00193	CcSEcCtD
Imiquimod—Tachycardia—Etoposide—muscle cancer	0.000952	0.00192	CcSEcCtD
Imiquimod—Abdominal pain—Vincristine—muscle cancer	0.000952	0.00192	CcSEcCtD
Imiquimod—Body temperature increased—Vincristine—muscle cancer	0.000952	0.00192	CcSEcCtD
Imiquimod—Skin disorder—Etoposide—muscle cancer	0.000948	0.00191	CcSEcCtD
Imiquimod—Erectile dysfunction—Methotrexate—muscle cancer	0.000947	0.00191	CcSEcCtD
Imiquimod—Hyperhidrosis—Etoposide—muscle cancer	0.000943	0.0019	CcSEcCtD
Imiquimod—Photosensitivity reaction—Methotrexate—muscle cancer	0.000938	0.00189	CcSEcCtD
Imiquimod—Breast disorder—Doxorubicin—muscle cancer	0.000931	0.00188	CcSEcCtD
Imiquimod—Anorexia—Etoposide—muscle cancer	0.00093	0.00188	CcSEcCtD
Imiquimod—Diarrhoea—Dactinomycin—muscle cancer	0.000923	0.00186	CcSEcCtD
Imiquimod—Infestation—Methotrexate—muscle cancer	0.000916	0.00185	CcSEcCtD
Imiquimod—Infestation NOS—Methotrexate—muscle cancer	0.000916	0.00185	CcSEcCtD
Imiquimod—Depression—Methotrexate—muscle cancer	0.000914	0.00184	CcSEcCtD
Imiquimod—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000909	0.00183	CcSEcCtD
Imiquimod—Conjunctivitis—Methotrexate—muscle cancer	0.000891	0.0018	CcSEcCtD
Imiquimod—Influenza—Doxorubicin—muscle cancer	0.00089	0.0018	CcSEcCtD
Imiquimod—Hypersensitivity—Vincristine—muscle cancer	0.000888	0.00179	CcSEcCtD
Imiquimod—Paraesthesia—Etoposide—muscle cancer	0.000876	0.00177	CcSEcCtD
Imiquimod—Dyspnoea—Etoposide—muscle cancer	0.00087	0.00176	CcSEcCtD
Imiquimod—Somnolence—Etoposide—muscle cancer	0.000868	0.00175	CcSEcCtD
Imiquimod—Hepatobiliary disease—Methotrexate—muscle cancer	0.000867	0.00175	CcSEcCtD
Imiquimod—Asthenia—Vincristine—muscle cancer	0.000864	0.00174	CcSEcCtD
Imiquimod—Vomiting—Dactinomycin—muscle cancer	0.000857	0.00173	CcSEcCtD
Imiquimod—Bronchitis—Doxorubicin—muscle cancer	0.000856	0.00173	CcSEcCtD
Imiquimod—Rash—Dactinomycin—muscle cancer	0.00085	0.00172	CcSEcCtD
Imiquimod—Decreased appetite—Etoposide—muscle cancer	0.000848	0.00171	CcSEcCtD
Imiquimod—Pancytopenia—Doxorubicin—muscle cancer	0.000845	0.00171	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Etoposide—muscle cancer	0.000842	0.0017	CcSEcCtD
Imiquimod—Fatigue—Etoposide—muscle cancer	0.000841	0.0017	CcSEcCtD
Imiquimod—Pain—Etoposide—muscle cancer	0.000834	0.00168	CcSEcCtD
Imiquimod—Dysuria—Doxorubicin—muscle cancer	0.000832	0.00168	CcSEcCtD
Imiquimod—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000827	0.00167	CcSEcCtD
Imiquimod—Haemoglobin—Methotrexate—muscle cancer	0.000827	0.00167	CcSEcCtD
Imiquimod—Diarrhoea—Vincristine—muscle cancer	0.000824	0.00166	CcSEcCtD
Imiquimod—Haemorrhage—Methotrexate—muscle cancer	0.000823	0.00166	CcSEcCtD
Imiquimod—Pharyngitis—Methotrexate—muscle cancer	0.000817	0.00165	CcSEcCtD
Imiquimod—Urinary tract disorder—Methotrexate—muscle cancer	0.000812	0.00164	CcSEcCtD
Imiquimod—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000812	0.00164	CcSEcCtD
Imiquimod—Urethral disorder—Methotrexate—muscle cancer	0.000806	0.00163	CcSEcCtD
Imiquimod—Feeling abnormal—Etoposide—muscle cancer	0.000804	0.00162	CcSEcCtD
Imiquimod—Nausea—Dactinomycin—muscle cancer	0.000801	0.00162	CcSEcCtD
Imiquimod—Gastrointestinal pain—Etoposide—muscle cancer	0.000798	0.00161	CcSEcCtD
Imiquimod—Dizziness—Vincristine—muscle cancer	0.000797	0.00161	CcSEcCtD
Imiquimod—Infestation NOS—Doxorubicin—muscle cancer	0.000794	0.0016	CcSEcCtD
Imiquimod—Infestation—Doxorubicin—muscle cancer	0.000794	0.0016	CcSEcCtD
Imiquimod—Visual impairment—Methotrexate—muscle cancer	0.000793	0.0016	CcSEcCtD
Imiquimod—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000787	0.00159	CcSEcCtD
Imiquimod—Erythema multiforme—Methotrexate—muscle cancer	0.000778	0.00157	CcSEcCtD
Imiquimod—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000778	0.00157	CcSEcCtD
Imiquimod—Urticaria—Etoposide—muscle cancer	0.000775	0.00156	CcSEcCtD
Imiquimod—Abdominal pain—Etoposide—muscle cancer	0.000771	0.00156	CcSEcCtD
Imiquimod—Body temperature increased—Etoposide—muscle cancer	0.000771	0.00156	CcSEcCtD
Imiquimod—Urinary tract infection—Doxorubicin—muscle cancer	0.000771	0.00156	CcSEcCtD
Imiquimod—Conjunctivitis—Doxorubicin—muscle cancer	0.000771	0.00156	CcSEcCtD
Imiquimod—Eye disorder—Methotrexate—muscle cancer	0.000769	0.00155	CcSEcCtD
Imiquimod—Tinnitus—Methotrexate—muscle cancer	0.000767	0.00155	CcSEcCtD
Imiquimod—Vomiting—Vincristine—muscle cancer	0.000766	0.00155	CcSEcCtD
Imiquimod—Rash—Vincristine—muscle cancer	0.00076	0.00153	CcSEcCtD
Imiquimod—Dermatitis—Vincristine—muscle cancer	0.000759	0.00153	CcSEcCtD
Imiquimod—Headache—Vincristine—muscle cancer	0.000755	0.00152	CcSEcCtD
Imiquimod—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000751	0.00151	CcSEcCtD
Imiquimod—Angiopathy—Methotrexate—muscle cancer	0.000746	0.00151	CcSEcCtD
Imiquimod—Sinusitis—Doxorubicin—muscle cancer	0.000745	0.0015	CcSEcCtD
Imiquimod—Immune system disorder—Methotrexate—muscle cancer	0.000743	0.0015	CcSEcCtD
Imiquimod—Mediastinal disorder—Methotrexate—muscle cancer	0.000741	0.0015	CcSEcCtD
Imiquimod—Chills—Methotrexate—muscle cancer	0.000738	0.00149	CcSEcCtD
Imiquimod—Alopecia—Methotrexate—muscle cancer	0.000727	0.00147	CcSEcCtD
Imiquimod—Mental disorder—Methotrexate—muscle cancer	0.000721	0.00145	CcSEcCtD
Imiquimod—Hypersensitivity—Etoposide—muscle cancer	0.000719	0.00145	CcSEcCtD
Imiquimod—Malnutrition—Methotrexate—muscle cancer	0.000716	0.00144	CcSEcCtD
Imiquimod—Erythema—Methotrexate—muscle cancer	0.000716	0.00144	CcSEcCtD
Imiquimod—Haemoglobin—Doxorubicin—muscle cancer	0.000716	0.00144	CcSEcCtD
Imiquimod—Nausea—Vincristine—muscle cancer	0.000716	0.00144	CcSEcCtD
Imiquimod—Rhinitis—Doxorubicin—muscle cancer	0.000714	0.00144	CcSEcCtD
Imiquimod—Haemorrhage—Doxorubicin—muscle cancer	0.000712	0.00144	CcSEcCtD
Imiquimod—Pharyngitis—Doxorubicin—muscle cancer	0.000707	0.00143	CcSEcCtD
Imiquimod—Urinary tract disorder—Doxorubicin—muscle cancer	0.000704	0.00142	CcSEcCtD
Imiquimod—Asthenia—Etoposide—muscle cancer	0.0007	0.00141	CcSEcCtD
Imiquimod—Connective tissue disorder—Doxorubicin—muscle cancer	0.0007	0.00141	CcSEcCtD
Imiquimod—Urethral disorder—Doxorubicin—muscle cancer	0.000698	0.00141	CcSEcCtD
Imiquimod—Back pain—Methotrexate—muscle cancer	0.000693	0.0014	CcSEcCtD
Imiquimod—Pruritus—Etoposide—muscle cancer	0.00069	0.00139	CcSEcCtD
Imiquimod—Visual impairment—Doxorubicin—muscle cancer	0.000687	0.00138	CcSEcCtD
Imiquimod—Erythema multiforme—Doxorubicin—muscle cancer	0.000674	0.00136	CcSEcCtD
Imiquimod—Diarrhoea—Etoposide—muscle cancer	0.000668	0.00135	CcSEcCtD
Imiquimod—Eye disorder—Doxorubicin—muscle cancer	0.000666	0.00134	CcSEcCtD
Imiquimod—Ill-defined disorder—Methotrexate—muscle cancer	0.000665	0.00134	CcSEcCtD
Imiquimod—Tinnitus—Doxorubicin—muscle cancer	0.000664	0.00134	CcSEcCtD
Imiquimod—Flushing—Doxorubicin—muscle cancer	0.000661	0.00133	CcSEcCtD
Imiquimod—Angiopathy—Doxorubicin—muscle cancer	0.000646	0.0013	CcSEcCtD
Imiquimod—Malaise—Methotrexate—muscle cancer	0.000646	0.0013	CcSEcCtD
Imiquimod—Dizziness—Etoposide—muscle cancer	0.000645	0.0013	CcSEcCtD
Imiquimod—Immune system disorder—Doxorubicin—muscle cancer	0.000643	0.0013	CcSEcCtD
Imiquimod—Mediastinal disorder—Doxorubicin—muscle cancer	0.000642	0.0013	CcSEcCtD
Imiquimod—Chills—Doxorubicin—muscle cancer	0.000639	0.00129	CcSEcCtD
Imiquimod—Arrhythmia—Doxorubicin—muscle cancer	0.000636	0.00128	CcSEcCtD
Imiquimod—Alopecia—Doxorubicin—muscle cancer	0.00063	0.00127	CcSEcCtD
Imiquimod—Cough—Methotrexate—muscle cancer	0.000625	0.00126	CcSEcCtD
Imiquimod—Mental disorder—Doxorubicin—muscle cancer	0.000624	0.00126	CcSEcCtD
Imiquimod—Convulsion—Methotrexate—muscle cancer	0.000621	0.00125	CcSEcCtD
Imiquimod—Vomiting—Etoposide—muscle cancer	0.00062	0.00125	CcSEcCtD
Imiquimod—Malnutrition—Doxorubicin—muscle cancer	0.00062	0.00125	CcSEcCtD
Imiquimod—Erythema—Doxorubicin—muscle cancer	0.00062	0.00125	CcSEcCtD
Imiquimod—Rash—Etoposide—muscle cancer	0.000615	0.00124	CcSEcCtD
Imiquimod—Dermatitis—Etoposide—muscle cancer	0.000615	0.00124	CcSEcCtD
Imiquimod—Headache—Etoposide—muscle cancer	0.000611	0.00123	CcSEcCtD
Imiquimod—Myalgia—Methotrexate—muscle cancer	0.00061	0.00123	CcSEcCtD
Imiquimod—Chest pain—Methotrexate—muscle cancer	0.00061	0.00123	CcSEcCtD
Imiquimod—Arthralgia—Methotrexate—muscle cancer	0.00061	0.00123	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000606	0.00122	CcSEcCtD
Imiquimod—Discomfort—Methotrexate—muscle cancer	0.000602	0.00122	CcSEcCtD
Imiquimod—Back pain—Doxorubicin—muscle cancer	0.0006	0.00121	CcSEcCtD
Imiquimod—Infection—Methotrexate—muscle cancer	0.000581	0.00117	CcSEcCtD
Imiquimod—Nausea—Etoposide—muscle cancer	0.00058	0.00117	CcSEcCtD
Imiquimod—Ill-defined disorder—Doxorubicin—muscle cancer	0.000575	0.00116	CcSEcCtD
Imiquimod—Nervous system disorder—Methotrexate—muscle cancer	0.000573	0.00116	CcSEcCtD
Imiquimod—Agitation—Doxorubicin—muscle cancer	0.00057	0.00115	CcSEcCtD
Imiquimod—Skin disorder—Methotrexate—muscle cancer	0.000568	0.00115	CcSEcCtD
Imiquimod—Hyperhidrosis—Methotrexate—muscle cancer	0.000565	0.00114	CcSEcCtD
Imiquimod—Malaise—Doxorubicin—muscle cancer	0.000559	0.00113	CcSEcCtD
Imiquimod—Anorexia—Methotrexate—muscle cancer	0.000557	0.00112	CcSEcCtD
Imiquimod—Syncope—Doxorubicin—muscle cancer	0.000556	0.00112	CcSEcCtD
Imiquimod—Palpitations—Doxorubicin—muscle cancer	0.000548	0.00111	CcSEcCtD
Imiquimod—Loss of consciousness—Doxorubicin—muscle cancer	0.000545	0.0011	CcSEcCtD
Imiquimod—Cough—Doxorubicin—muscle cancer	0.000541	0.00109	CcSEcCtD
Imiquimod—Convulsion—Doxorubicin—muscle cancer	0.000537	0.00108	CcSEcCtD
Imiquimod—Hypertension—Doxorubicin—muscle cancer	0.000535	0.00108	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000533	0.00107	CcSEcCtD
Imiquimod—Insomnia—Methotrexate—muscle cancer	0.000529	0.00107	CcSEcCtD
Imiquimod—Arthralgia—Doxorubicin—muscle cancer	0.000528	0.00107	CcSEcCtD
Imiquimod—Chest pain—Doxorubicin—muscle cancer	0.000528	0.00107	CcSEcCtD
Imiquimod—Myalgia—Doxorubicin—muscle cancer	0.000528	0.00107	CcSEcCtD
Imiquimod—Anxiety—Doxorubicin—muscle cancer	0.000526	0.00106	CcSEcCtD
Imiquimod—Paraesthesia—Methotrexate—muscle cancer	0.000525	0.00106	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000524	0.00106	CcSEcCtD
Imiquimod—Discomfort—Doxorubicin—muscle cancer	0.000522	0.00105	CcSEcCtD
Imiquimod—Dyspnoea—Methotrexate—muscle cancer	0.000521	0.00105	CcSEcCtD
Imiquimod—Somnolence—Methotrexate—muscle cancer	0.00052	0.00105	CcSEcCtD
Imiquimod—Dry mouth—Doxorubicin—muscle cancer	0.000516	0.00104	CcSEcCtD
Imiquimod—Dyspepsia—Methotrexate—muscle cancer	0.000515	0.00104	CcSEcCtD
Imiquimod—Decreased appetite—Methotrexate—muscle cancer	0.000508	0.00103	CcSEcCtD
Imiquimod—Oedema—Doxorubicin—muscle cancer	0.000506	0.00102	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000505	0.00102	CcSEcCtD
Imiquimod—Fatigue—Methotrexate—muscle cancer	0.000504	0.00102	CcSEcCtD
Imiquimod—Infection—Doxorubicin—muscle cancer	0.000503	0.00101	CcSEcCtD
Imiquimod—Pain—Methotrexate—muscle cancer	0.0005	0.00101	CcSEcCtD
Imiquimod—Shock—Doxorubicin—muscle cancer	0.000498	0.001	CcSEcCtD
Imiquimod—Nervous system disorder—Doxorubicin—muscle cancer	0.000496	0.001	CcSEcCtD
Imiquimod—Tachycardia—Doxorubicin—muscle cancer	0.000494	0.000997	CcSEcCtD
Imiquimod—Skin disorder—Doxorubicin—muscle cancer	0.000492	0.000992	CcSEcCtD
Imiquimod—Hyperhidrosis—Doxorubicin—muscle cancer	0.000489	0.000987	CcSEcCtD
Imiquimod—Anorexia—Doxorubicin—muscle cancer	0.000482	0.000973	CcSEcCtD
Imiquimod—Feeling abnormal—Methotrexate—muscle cancer	0.000482	0.000972	CcSEcCtD
Imiquimod—Gastrointestinal pain—Methotrexate—muscle cancer	0.000478	0.000964	CcSEcCtD
Imiquimod—Urticaria—Methotrexate—muscle cancer	0.000464	0.000937	CcSEcCtD
Imiquimod—Abdominal pain—Methotrexate—muscle cancer	0.000462	0.000932	CcSEcCtD
Imiquimod—Body temperature increased—Methotrexate—muscle cancer	0.000462	0.000932	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000461	0.00093	CcSEcCtD
Imiquimod—Insomnia—Doxorubicin—muscle cancer	0.000458	0.000923	CcSEcCtD
Imiquimod—Paraesthesia—Doxorubicin—muscle cancer	0.000454	0.000917	CcSEcCtD
Imiquimod—Dyspnoea—Doxorubicin—muscle cancer	0.000451	0.00091	CcSEcCtD
Imiquimod—Somnolence—Doxorubicin—muscle cancer	0.00045	0.000908	CcSEcCtD
Imiquimod—Dyspepsia—Doxorubicin—muscle cancer	0.000446	0.000899	CcSEcCtD
Imiquimod—Decreased appetite—Doxorubicin—muscle cancer	0.00044	0.000888	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000437	0.000882	CcSEcCtD
Imiquimod—Fatigue—Doxorubicin—muscle cancer	0.000436	0.00088	CcSEcCtD
Imiquimod—Pain—Doxorubicin—muscle cancer	0.000433	0.000873	CcSEcCtD
Imiquimod—Hypersensitivity—Methotrexate—muscle cancer	0.000431	0.000869	CcSEcCtD
Imiquimod—Asthenia—Methotrexate—muscle cancer	0.000419	0.000846	CcSEcCtD
Imiquimod—Feeling abnormal—Doxorubicin—muscle cancer	0.000417	0.000841	CcSEcCtD
Imiquimod—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000414	0.000835	CcSEcCtD
Imiquimod—Pruritus—Methotrexate—muscle cancer	0.000414	0.000834	CcSEcCtD
Imiquimod—Urticaria—Doxorubicin—muscle cancer	0.000402	0.000811	CcSEcCtD
Imiquimod—Abdominal pain—Doxorubicin—muscle cancer	0.0004	0.000807	CcSEcCtD
Imiquimod—Body temperature increased—Doxorubicin—muscle cancer	0.0004	0.000807	CcSEcCtD
Imiquimod—Diarrhoea—Methotrexate—muscle cancer	0.0004	0.000807	CcSEcCtD
Imiquimod—Dizziness—Methotrexate—muscle cancer	0.000387	0.00078	CcSEcCtD
Imiquimod—Hypersensitivity—Doxorubicin—muscle cancer	0.000373	0.000752	CcSEcCtD
Imiquimod—Vomiting—Methotrexate—muscle cancer	0.000372	0.00075	CcSEcCtD
Imiquimod—Rash—Methotrexate—muscle cancer	0.000369	0.000743	CcSEcCtD
Imiquimod—Dermatitis—Methotrexate—muscle cancer	0.000368	0.000743	CcSEcCtD
Imiquimod—Headache—Methotrexate—muscle cancer	0.000366	0.000739	CcSEcCtD
Imiquimod—Asthenia—Doxorubicin—muscle cancer	0.000363	0.000733	CcSEcCtD
Imiquimod—Pruritus—Doxorubicin—muscle cancer	0.000358	0.000722	CcSEcCtD
Imiquimod—Nausea—Methotrexate—muscle cancer	0.000347	0.0007	CcSEcCtD
Imiquimod—Diarrhoea—Doxorubicin—muscle cancer	0.000346	0.000699	CcSEcCtD
Imiquimod—Dizziness—Doxorubicin—muscle cancer	0.000335	0.000675	CcSEcCtD
Imiquimod—Vomiting—Doxorubicin—muscle cancer	0.000322	0.000649	CcSEcCtD
Imiquimod—Rash—Doxorubicin—muscle cancer	0.000319	0.000644	CcSEcCtD
Imiquimod—Dermatitis—Doxorubicin—muscle cancer	0.000319	0.000643	CcSEcCtD
Imiquimod—Headache—Doxorubicin—muscle cancer	0.000317	0.00064	CcSEcCtD
Imiquimod—Nausea—Doxorubicin—muscle cancer	0.000301	0.000606	CcSEcCtD
